BAAM
ELV icon

Baker Avenue Asset Management’s Elevance Health ELV Stock Holding History

Baker Avenue Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-116
Closed -$50.5K – 687
2023
Q3 		$50.5K Sell
116
-59
-34% -$26.8K ﹤0.01% 519
2023
Q2 		$77.8K Sell
175
-80
-31% -$36.9K ﹤0.01% 461
2023
Q1 		$117K Sell
255
-17
-6% -$8.09K 0.01% 413
2022
Q4 		$140K Buy
+272
New +$138K 0.01% 368

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baker Avenue Asset Management's ELV Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 116 shares — an estimated $50.5K sold.

Baker Avenue Asset Management first reported a position in ELV in Q4 2022 and held it in 4 quarters. The position peaked at $140K in Q4 2022. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 116 Elevance Health shares in Q4 2023, an estimated $50.5K.
  • Baker Avenue Asset Management first reported a position in Elevance Health in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's Elevance Health position peaked at $140K in Q4 2022.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.